Back to results
US 2026/0259197 A1Published application
Covid-19 and respiratory disease virus infection models using lung organoids
AssigneeThe Catholic University of Korea Industry-Academic Cooperation Foundation
InventorsSung Won KIM, Ayoung JO, Min Jae LIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a COVID-19 infection model using alveolar organoids. Respiratory virus-infected alveolar organoids produced according to the present invention are expected to be usefully used in preclinical or clinical drug screening and the like for the development of therapeutic agents for SARS-CoV-2 infection.
Claims9
A method for producing a respiratory virus-infected alveolar organoid, the method comprising infecting an alveolar organoid with a respiratory virus.
(canceled)
Dependencies are inferred from the claim text.